Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Shaji K. Kumar, Simon J. Harrison, Michele Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto, Vania Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, Elizabeth A. Punnoose, Wan Jen Hong, Kevin J. Freise, Xiaoqing Yang, Anjla Sood, Muhammad Jalaluddin, Jeremy A. Ross, James E. Ward, Paulo C. Maciag, Philippe Moreau
Dive into the research topics of 'Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial'. Together they form a unique fingerprint.